- ICH GCP
- Registre américain des essais cliniques
- Essai clinique NCT02393651
Late LTP-like Plasticity Effects of tDCS in Subacute Stroke Patients
Rationale: About 80% of stroke patients suffer motor impairments, but current therapies have limited effects on motor recovery. Therefore, investigating new potential therapeutic approaches is crucial. Transcranial Direct Current Stimulation (tDCS) is a form of non-invasive electrical stimulation where a weak current is applied through electrodes over the scalp. This stimulation is known to (1) induce changes in neuronal excitability -which can last up to one day with late LTP-like plasticity protocols in a polarity and site-specific manner, and (2) facilitate motor learning and stroke recovery. So far, several pilot studies have reported beneficial results from tDCS in both subacute and chronic stroke patients, but it's still unclear how tDCS should be repeated over multiple days to optimally enhance recovery and training effects. Using a late LTP-like plasticity protocol could increase effectiveness of standard clinical care rehabilitation sessions and thus enhance the effects of rehabilitation. Therefore, the investigators want to investigate how late LTP-like plasticity tDCS affects rehabilitation in subacute stroke patients. The outcome of this study can provide important guidelines on effective motor therapy during stroke rehabilitation.
Objective: Identify the effect of late LTP-like plasticity on motor rehabilitation during the subacute phase after stroke.
Study design: Double-blinded, randomized between-subjects trials. Study population: Subacute stroke patients. Main study parameters/endpoints: The primary outcome measure is the upper limb motor function during the subacute phase after stroke.
Aperçu de l'étude
Statut
Les conditions
Intervention / Traitement
Type d'étude
Inscription (Anticipé)
Phase
- N'est pas applicable
Contacts et emplacements
Lieux d'étude
-
-
Zuid-Holland
-
Rotterdam, Zuid-Holland, Pays-Bas, 3015LJ
- Recrutement
- Rijndam
-
Contact:
- Gerard Ribbers, PhD MD
- Numéro de téléphone: +31102412411
- E-mail: gribbers@rijndam.nl
-
-
Critères de participation
Critère d'éligibilité
Âges éligibles pour étudier
Accepte les volontaires sains
Sexes éligibles pour l'étude
La description
Inclusion Criteria:
- Subacute stroke (within 1-4 weeks post stroke)
- Acute hemiparesis (Fugl-Meyer Stage < IV) with single thromboembolic non-hemorrhagic infarction documented by a neurologist
- Aged 18-79
Exclusion Criteria:
- Absence of voluntary movement (Fugl-Meyer Stage < III)
- Head injury or the presence of intracranial metal or intracranial lesions
- History of cranial irradiation
- History of epilepsy
- Presence of a pacemaker
- Taking anticonvulsant or neuroleptic medication
- Substance abuse
- Inability to understand instructions
Plan d'étude
Comment l'étude est-elle conçue ?
Détails de conception
- Objectif principal: Traitement
- Répartition: Randomisé
- Modèle interventionnel: Affectation parallèle
- Masquage: Quadruple
Armes et Interventions
Groupe de participants / Bras |
Intervention / Traitement |
|---|---|
|
Comparateur placebo: Sham
Motor training of the affected upper extremity combined with sham tDCS.
|
Late LTP-like plasticity tDCS (2 times per week) for 4 weeks.
|
|
Expérimental: tDCS
Motor training of the affected upper extremity combined with dual transcranial direct current stimulation (tDCS).
|
Late LTP-like plasticity tDCS (2 times per week) for 4 weeks.
|
Que mesure l'étude ?
Principaux critères de jugement
Mesure des résultats |
Délai |
|---|---|
|
Change from baseline in Upper Extremity Fugl Meyer Assessment
Délai: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Mesures de résultats secondaires
Mesure des résultats |
Délai |
|---|---|
|
ARAT
Délai: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
Hand grip strength
Délai: Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline, 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
10-meter walk test
Délai: Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
EuroQol-5D
Délai: 12 weeks
|
12 weeks
|
|
Barthel Index
Délai: Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
Baseline; 1 week, 2 weeks, 4 weeks and 12 weeks
|
|
HADS
Délai: Baseline; 4 weeks and 12 weeks
|
Baseline; 4 weeks and 12 weeks
|
|
MoCA
Délai: Baseline; 4 weeks and 12 weeks
|
Baseline; 4 weeks and 12 weeks
|
|
Wong-Baker FACES Pain Rating Scale
Délai: Every stimulation session
|
Every stimulation session
|
Collaborateurs et enquêteurs
Parrainer
Publications et liens utiles
Dates d'enregistrement des études
Dates principales de l'étude
Début de l'étude
Achèvement primaire (Anticipé)
Achèvement de l'étude (Anticipé)
Dates d'inscription aux études
Première soumission
Première soumission répondant aux critères de contrôle qualité
Première publication (Estimation)
Mises à jour des dossiers d'étude
Dernière mise à jour publiée (Réel)
Dernière mise à jour soumise répondant aux critères de contrôle qualité
Dernière vérification
Plus d'information
Termes liés à cette étude
Termes MeSH pertinents supplémentaires
Autres numéros d'identification d'étude
- MEC-2014-503
- NL49887.078.14 (Autre identifiant: CCMO)
Ces informations ont été extraites directement du site Web clinicaltrials.gov sans aucune modification. Si vous avez des demandes de modification, de suppression ou de mise à jour des détails de votre étude, veuillez contacter register@clinicaltrials.gov. Dès qu'un changement est mis en œuvre sur clinicaltrials.gov, il sera également mis à jour automatiquement sur notre site Web .